The Inventory of Depressive Symptomatology (IDS): Clinician (IDS‐C) and Self‐Report (IDS‐SR) ratings of depressive symptoms

By A. Rush, T. Carmody, P. Reimitz. 2000

405 citations recorded by the source corpus.

Subfields: Cognitive Neuroscience, Experimental and Cognitive Psychology, Pharmacology

View Paper: https://www.semanticscholar.org/paper/ad89dcad8fe7d451788cea25d3c025379e2c5277

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cognitive Neuroscience

1. Maurizio Fava
2. Joelle Pineau
3. Marc G. Bellemare
4. Luke Clark
5. Marion Leboyer
6. Madhukar H. Trivedi
7. M. Thase
8. E. Bora

In Experimental and Cognitive Psychology

1. Susan A. Murphy
2. Alan M. Zaslavsky
3. Ronald C. Kessler
4. È. Hiripi
5. Marc G. Bellemare
6. A. Rush
7. Luke Clark
8. David J. Kupfer

In Pharmacology

1. Susan A. Murphy
2. Maurizio Fava
3. David J. Kupfer
4. C. Apovian
5. Daniel J. Lizotte
6. Michael H. Bowling
7. Michael R. Kosorok
8. Eric B. Laber

Citations in the corpus

• Constructing evidence-based treatment strategies using methods from computer science. (2007, positive): “Symptom severity is defined by the Quick Inventory of Depressive Symptomatology (QIDS-SR 16 : Rush et al., 2000;Trivedi et al., 2004;Rush et al., 2003), which is a short and self-report version of the Inventory of Depressive Symptomatology (IDS: Rush et al. 1996).”
• A Randomized, Phase 3 Trial of Naltrexone SR/Bupropion SR on Weight and Obesity-related Risk Factors (COR-II) (2013, methodology): “Self Rated (IDS-SR) (18).”
• Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. (2004, methodology): “Symptomatic status is measured by the QIDS-C16 [40–42].”
• The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation (2004, methodology): “They are also in agreement with a previous report revealing good convergent validity of the QIDS-SR16 and IDS-SR30 (Rush et al. 2000).”
• Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta‐analysis (2013, methodology): “Where mood scores were available, euthymia was defined as 8 on Hamilton Depression Rating Scale (HDRS) (51) or 15 on Montgomery– Asberg Depression Rating Scale (MADRS) (52) or 11 on Inventory of Depressive Symptomatology (Clinician Rating; IDS-C) (53) and 8 on Young Mania Rating Scale (YMRS) (54) or”
• Short screening scales to monitor population prevalences and trends in non-specific psychological distress (2002, methodology): “The K6 was subsequently included in the 1997 (N¯ 36116) and 1998 (N¯ 32440) US National Health Interview Survey, while the K10 was included in the 1997 (N¯ 10641) Australian National Survey of Mental Health and Well-Being.”